CD4 and neoplasm: Similarly, the percentages of CD4+ CD25− conventional T-cell subset in the spleen were significantly increased on day 21 and 28 after the treatment (Figure 2d, P<0.01 compared with the control group on day 26 after tumor inoculation), along with a higher IFN-γ level (Figures 4a–c).